Violation Tracker Agency Summary Page
Agency Name:
Multistate Attorneys General Case
Penalty Total since 2000:
$105,875,362,465
Number of Records:
644
Note:
The penalty total above and the parent totals below include some cases in which both a state and a federal agency were involved and issued separate announcements of the outcome. The individual penalty records below marked by an asterisk are ones for which Violation Tracker contains a separate federal entry. The state attorney general cases below include only those brought by this state alone. For cases brought together with other states, see the summary page for Multistate Attorneys General Cases.
| Top 10 Parent Companies | Total Penalty $ | Number of Records |
|---|---|---|
| Bank of America | $26,114,848,408 | 10 |
| UBS | $11,393,380,000 | 5 |
| Citigroup | $8,231,391,577 | 6 |
| JPMorgan Chase | $6,208,338,661 | 10 |
| BP | $4,910,000,000 | 2 |
| American Electric Power | $4,687,500,000 | 3 |
| Morgan Stanley | $4,060,000,000 | 3 |
| Goldman Sachs | $3,690,833,333 | 3 |
| Deutsche Bank | $3,648,333,333 | 3 |
| Wells Fargo | $1,872,683,716 | 8 |
Individual Penalty Records:
Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as 
or XML
or XML
| Company | Parent | Parent Major Industry | Primary Offense Type | Year |
Penalty Amount |
|---|---|---|---|---|---|
| UBS Securities LLC and UBS Financial Services, Inc. | UBS | financial services | investor protection violation | 2008 | $11,150,000,000 |
| Countrywide Home Loans | Bank of America | financial services | mortgage abuses | 2008 | $8,680,000,000 |
| Citigroup Global Markets, Inc. and Citi Smith Barney | Citigroup | financial services | investor protection violation | 2008 | $7,100,000,000 |
| BP | BP | oil and gas | environmental violation | 2015 | (*) $4,900,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | environmental violation | 2007 | (*) $4,675,000,000 |
| Banc of America Securities LLC | Bank of America | financial services | investor protection violation | 2008 | $4,550,000,000 |
| Morgan Stanley | Morgan Stanley | financial services | investor protection violation | 2008 | $3,535,000,000 |
| JP Morgan Chase & Co. | JPMorgan Chase | financial services | investor protection violation | 2008 | $3,525,000,000 |
| Merrill Lynch & Co. | Bank of America | financial services | investor protection violation | 2008 | $3,458,333,333 |
| Goldman Sachs Group, Inc. | Goldman Sachs | financial services | investor protection violation | 2008 | $3,355,833,333 |
| Deutsche Bank Securities, Inc. and Deutsche Bank AG | Deutsche Bank | financial services | investor protection violation | 2008 | $3,348,333,333 |
| Countrywide Financial Corporation | Bank of America | financial services | mortgage abuses | 2010 | $3,004,100,000 |
| Bank of America | Bank of America | financial services | investor protection violation | 2012 | $2,430,000,000 |
| Bank of America | Bank of America | financial services | mortgage abuses | 2012 | (*) $2,382,415,075 |
| Enron | Enron | utilities and power generation | energy market manipulation | 2005 | $1,520,000,000 |
| El Paso Corporation | Kinder Morgan | pipelines | energy market manipulation | 2003 | $1,450,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | mortgage abuses | 2012 | (*) $1,121,188,661 |
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | (*) $1,066,000,000 |
| Wells Fargo | Wells Fargo | financial services | mortgage abuses | 2012 | (*) $1,005,233,716 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2014 | (*) $943,000,000 |
| RBC Capital Markets Corporation | Royal Bank of Canada | financial services | investor protection violation | 2008 | $859,800,000 |
| Standard & Poor's Financial Services LLC | S&P Global | information technology | toxic securities abuses | 2015 | (*) $687,500,000 |
| TK Holdings Inc. | Ningbo Joyson Electronic | automotive parts | consumer protection violation | 2018 | $650,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $612,000,000 |
| Wells Fargo Bank N.A. | Wells Fargo | financial services | banking violation | 2018 | $575,000,000 |
| Volkswagen | Volkswagen | motor vehicles | environmental violation | 2016 | (*) $570,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $541,000,000 |
| Bank of America | Bank of America | financial services | investor protection violation | 2013 | $500,000,000 |
| Career Education Corp. | Career Education Corp. | miscellaneous services | consumer protection violation | 2019 | $498,700,000 |
| Household Finance Corp. | HSBC | financial services | mortgage abuses | 2002 | $484,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $477,792,391 |
| Mylan Inc. | Mylan | pharmaceuticals | False Claims Act and related | 2017 | (*) $465,000,000 |
| Reliant Energy, Inc. | NRG Energy | utilities and power generation | energy market manipulation | 2005 | $460,000,000 |
| TD Ameritrade, Inc. | TD Ameritrade | financial services | investor protection violation | 2009 | $456,000,000 |
| Apple Inc. | Apple Inc. | electrical and electronic equipment | price-fixing or anti-competitive practices | 2014 | $450,000,000 |
| Moody's Corporation | Moody's | information technology | toxic securities abuses | 2017 | $426,500,000 |
| Williams Energy Marketing & Trading | Williams Companies | oil and gas | energy market manipulation | 2002 | $417,000,000 |
| Citigroup | Citigroup | financial services | mortgage abuses | 2012 | (*) $413,041,577 |
| Marsh and McLennan | Marsh & McLennan | financial services | investor protection violation | 2009 | $400,000,000 |
| Salomon Smith Barney Inc. | Morgan Stanley | financial services | investor protection violation | 2002 | (*) $400,000,000 |
| LG Display Co., Ltd. | LG | diversified | price-fixing or anti-competitive practices | 2012 | $380,000,000 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | (*) $371,351,180 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | (*) $361,828,456 |
| Archer Daniels Midland Company | Archer Daniels Midland | agribusiness | environmental violation | 2003 | (*) $350,900,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $339,148,643 |
| Pfizer, Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2009 | (*) $331,485,170 |
| Ameriquest Mortgage | Citigroup | financial services | consumer protection violation | 2006 | $325,000,000 |
| Invesco Funds Group | Invesco | financial services | securities issuance or trading violation | 2004 | (*) $325,000,000 |
| MCI | Verizon Communications | telecommunications | tax violations | 2005 | $315,000,000 |
| Olympus Corporation of the Americas | Olympus | electrical and electronic equipment | False Claims Act and related | 2016 | (*) $306,000,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | kickbacks and bribery | 2004 | (*) $292,969,482 |
| Citigroup Inc. | Citigroup | financial services | toxic securities abuses | 2014 | (*) $291,750,000 |
| Merck | Merck | pharmaceuticals | False Claims Act and related | 2008 | (*) $290,000,000 |
| Prudential Equity Group | Prudential Financial | financial services | securities issuance or trading violation | 2006 | (*) $270,000,000 |
| Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2013 | (*) $266,729,715 |
| Serono Inc. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | (*) $262,000,000 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $257,400,000 |
| Samsung Electronics, Co., Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2011 | $240,000,000 |
| Goldman Sachs | Goldman Sachs | financial services | toxic securities abuses | 2016 | (*) $225,000,000 |
| Janus Capital Management | Janus Henderson | financial services | securities issuance or trading violation | 2004 | $225,000,000 |
| Deutsche Bank | Deutsche Bank | financial services | interest rate benchmark manipulation | 2017 | $220,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*) $218,092,993 |
| Duke Energy | Duke Energy | utilities and power generation | energy market manipulation | 2004 | $207,500,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $201,975,000 |
| Credit Suisse First Boston Corp. | Credit Suisse | financial services | investor protection violation | 2002 | (*) $200,000,000 |
| Reckitt Benckiser Group | Reckitt Benckiser | household and personal care products | Controlled Substances Act violation | 2019 | (*) $200,000,000 |
| WellCare Health Plans Inc. | WellCare Health Plans | healthcare services | investor protection violation | 2010 | $200,000,000 |
| Aequitas Capital Management Inc. | consumer protection violation | 2017 | $192,000,000 | ||
| Aon Corporation | Aon | financial services | price-fixing or anti-competitive practices | 2005 | $190,000,000 |
| Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | (*) $190,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | (*) $187,000,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $181,000,000 |
| Equifax | Equifax | miscellaneous services | privacy violation | 2019 | $175,000,000 |
| Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | (*) $173,000,000 |
| Zurich American Insurance Company | Zurich Insurance | financial services | price-fixing or anti-competitive practices | 2006 | $171,700,000 |
| AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | $170,000,000 |
| Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | $169,000,000 |
| Student CU Connect CUSO, LLC | consumer protection violation | 2019 | (*) $168,000,000 | ||
| SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | (*) $163,560,000 |
| Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | (*) $160,000,000 |
| Volkswagen AG | Volkswagen | motor vehicles | environmental violation | 2017 | $157,000,000 |
| Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | $154,000,000 |
| McKesson Corporation | McKesson | wholesalers | False Claims Act and related | 2012 | $151,000,000 |
| Brown & Williamson Tobacco | British American Tobacco | tobacco | tobacco litigation | 2003 | $150,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | investor protection violation | 2015 | $150,000,000 |
| Uber Technologies | Uber Technologies | miscellaneous services | consumer protection violation | 2018 | $148,000,000 |
| Pershing Square Capital Management | investor protection violation | 2017 | $145,000,000 | ||
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | investor protection violation | 2017 | $145,000,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $142,494,000 |
| WellCare Health Plans Inc. | WellCare Health Plans | healthcare services | False Claims Act and related | 2012 | (*) $137,500,000 |
| Ocwen Financial Services | Ocwen Financial | financial services | mortgage abuses | 2013 | (*) $127,300,000 |
| AIM Advisors | Invesco | financial services | securities issuance or trading violation | 2004 | (*) $125,000,000 |
| Cephalon | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2016 | $125,000,000 |
| Morgan Stanley | Morgan Stanley | financial services | investor protection violation | 2002 | (*) $125,000,000 |
| King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2006 | (*) $124,000,000 |
| Tenet Healthcare Corporation | Tenet Healthcare | healthcare services | kickbacks and bribery | 2016 | (*) $123,772,464 |
| Maxim Healthcare Services, Inc. | Maxim Healthcare Services | miscellaneous services | False Claims Act and related | 2011 | (*) $121,514,199 |
| General Motors Company | General Motors | motor vehicles | motor vehicle safety violation | 2017 | $120,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | $120,000,000 |
| Lender Processing Services, Inc. | Fidelity National Financial | financial services | mortgage abuses | 2013 | $120,000,000 |
| Mylan Pharmaceuticals, Inc. | Mylan | pharmaceuticals | False Claims Act and related | 2009 | (*) $118,000,000 |
Download results as or XML
or XML
